Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation

Clinical Trial Description

The objective of this study is to use previously collected retrospective observational data to compare treatment and outcome in patients treated with CroFab who have a severe envenomation to those with a mild/moderate envenomation. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT02877498` - A Study to Compare Adaptive Support Ventilation vs. Volume Controlled Ventilation for Management of Respiratory Failure in Patients With Neuroparalytic Snake Envenomation	N/A
Terminated	`NCT00303303` - The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations	Phase 4
Not yet recruiting	`NCT06304714` - Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana

See also

Status

Clinical Trial

Phase

Completed

NCT02877498 - A Study to Compare Adaptive Support Ventilation vs. Volume Controlled Ventilation for Management of Respiratory Failure in Patients With Neuroparalytic Snake Envenomation

N/A

Terminated

NCT00303303 - The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations

Phase 4

Not yet recruiting

NCT06304714 - Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00927381
Study type	Observational
Source	BTG International Inc.
Contact
Status	Completed
Phase
Start date	January 2005
Completion date	January 2005

Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms